Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00610558 · ClinicalTrials.gov registry record · NA
Neocortical Epilepsies - Do They Progress?
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00610558 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 60 participants.
The verdict
NCT00610558, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study will use MRI and PET scan to compare the brain imaging results between epilepsy patients and normal healthy controls, also to study changes in 3 years.
Interventions
- DEVICE Arm 1: Juvenile Myoclonic Epilepsy
- DEVICE Arm 2: Frontal Lobe Epilepsy
- DEVICE Arm 3: Normal Controls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2003-07 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00610558
The ClinicalTrials.gov registry entry for NCT00610558 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Arm 1: Juvenile Myoclonic Epilepsy is the first listed.
NCT00610558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00610558 about?
NCT00610558 is a clinical study titled "Neocortical Epilepsies - Do They Progress?". This study will use MRI and PET scan to compare the brain imaging results between epilepsy patients and normal healthy controls, also to study changes in 3 years.
What is the current status of trial NCT00610558?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2003-07. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00610558?
The interventions under investigation include: Arm 1: Juvenile Myoclonic Epilepsy (DEVICE), Arm 2: Frontal Lobe Epilepsy (DEVICE), Arm 3: Normal Controls (DEVICE).
Who is sponsoring clinical trial NCT00610558?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.